Analyst Price Target is $12.25
▲ +231.08% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Apyx Medical in the last 3 months. The average price target is $12.25, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 231.08% upside from the last price of $3.70.
Current Consensus is
The current consensus among 4 polled investment analysts is to buy stock in Apyx Medical. This Buy consensus rating has held steady for over two years.
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.